What are the Merck Pregnancy Registries?
Merck’s Worldwide Product Safety & Epidemiology department has been operating a Pregnancy Registry Program since 1995. Pregnancy registries are prospective active data collection systems which can facilitate the early detection of teratogenicity and other serious adverse experiences in patients who inadvertently or purposefully use a drug during pregnancy. Useful information about the outcome of exposure in pregnancy can best be obtained by the careful collection and analysis of post-marketing surveillance data. Reports of the aggregate data in each Registry are updated annually and are available to US health care providers upon request. (In countries outside of the United States, information is available through the local Merck subsidiary).
Merck’s Worldwide Product Safety & Epidemiology department has been operating a Pregnancy Registry Program since 1995. Pregnancy registries are prospective active data collection systems that can facilitate the early detection of teratogenicity and other serious adverse experiences in patients who inadvertently or purposefully use a drug during pregnancy. Useful information about the outcome of exposure in pregnancy can best be obtained by the careful collection and analysis of post-marketing surveillance data. Reports of the aggregate data in each Registry are updated annually and are available to US health care providers upon request. (In countries outside of the United States, information is available through the local Merck subsidiary).
